 | • レポートコード：QYR9ST09242 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、神経内分泌腫瘍（NET）治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ソマトスタチンアナログ（SSA）、標的療法、その他に、用途別には、病院、診療所、その他にセグメント区分し、神経内分泌腫瘍（NET）治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・神経内分泌腫瘍（NET）治療の世界市場概要 ・神経内分泌腫瘍（NET）治療の製造コスト構成分析 ・神経内分泌腫瘍（NET）治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・神経内分泌腫瘍（NET）治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・神経内分泌腫瘍（NET）治療のセグメント分析（種類別） （ソマトスタチンアナログ（SSA）、標的療法、その他） ・神経内分泌腫瘍（NET）治療のセグメント分析（用途別） （病院、診療所、その他） ・神経内分泌腫瘍（NET）治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Advanced Accelerator Applications、AVEO Oncology、Boehringer Ingelheim International、Hutchison MediPharma Limited、IpsenPharma、Novartis AG、Pfizer, Inc、Progenics Pharmaceuticals） ・神経内分泌腫瘍（NET）治療の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discovered in the late 1970’s, emotional responses are composed of neuropeptides (amino acid chains) and their receptors, which lie on neurons and other cells of remote tissues in the body. The neuropeptides are ejected from the neuron and carry the encoded “information” to other sites within the body. These neuropeptides are in a category of neurochemicals known as Information Substances (IS). ISs are released at times of stress-related arousal and become attached to remotely-positioned neuroreceptors.
The global Neuroendocrine Tumors (NETs) Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neuroendocrine Tumors (NETs) Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroendocrine Tumors (NETs) Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroendocrine Tumors (NETs) Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroendocrine Tumors (NETs) Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Advanced Accelerator Applications
AVEO Oncology
Boehringer Ingelheim International
Hutchison MediPharma Limited
IpsenPharma
Novartis AG
Pfizer, Inc
Progenics Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Somatostatin Analogs (SSAs)
Targeted Therapy
Other
Segment by Application
Hospitals
Clinics
Other
Table of Contents
Executive Summary
1 Industry Overview of Neuroendocrine Tumors (NETs) Treatment
1.1 Definition of Neuroendocrine Tumors (NETs) Treatment
1.2 Neuroendocrine Tumors (NETs) Treatment Segment by Type
1.2.1 Global Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Somatostatin Analogs (SSAs)
1.2.3 Targeted Therapy
1.2.4 Other
1.3 Neuroendocrine Tumors (NETs) Treatment Segment by Applications
1.3.1 Global Neuroendocrine Tumors (NETs) Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Neuroendocrine Tumors (NETs) Treatment Overall Market
1.4.1 Global Neuroendocrine Tumors (NETs) Treatment Revenue (2014-2025)
1.4.2 Global Neuroendocrine Tumors (NETs) Treatment Production (2014-2025)
1.4.3 North America Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
1.4.4 Europe Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
1.4.5 China Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
1.4.6 Japan Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
1.4.8 India Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Tumors (NETs) Treatment
2.3 Manufacturing Process Analysis of Neuroendocrine Tumors (NETs) Treatment
2.4 Industry Chain Structure of Neuroendocrine Tumors (NETs) Treatment
3 Development and Manufacturing Plants Analysis of Neuroendocrine Tumors (NETs) Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Neuroendocrine Tumors (NETs) Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroendocrine Tumors (NETs) Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Neuroendocrine Tumors (NETs) Treatment Production and Capacity Analysis
4.2 Neuroendocrine Tumors (NETs) Treatment Revenue Analysis
4.3 Neuroendocrine Tumors (NETs) Treatment Price Analysis
4.4 Market Concentration Degree
5 Neuroendocrine Tumors (NETs) Treatment Regional Market Analysis
5.1 Neuroendocrine Tumors (NETs) Treatment Production by Regions
5.1.1 Global Neuroendocrine Tumors (NETs) Treatment Production by Regions
5.1.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue by Regions
5.2 Neuroendocrine Tumors (NETs) Treatment Consumption by Regions
5.3 North America Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.3.1 North America Neuroendocrine Tumors (NETs) Treatment Production
5.3.2 North America Neuroendocrine Tumors (NETs) Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroendocrine Tumors (NETs) Treatment Import and Export
5.4 Europe Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.4.1 Europe Neuroendocrine Tumors (NETs) Treatment Production
5.4.2 Europe Neuroendocrine Tumors (NETs) Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroendocrine Tumors (NETs) Treatment Import and Export
5.5 China Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.5.1 China Neuroendocrine Tumors (NETs) Treatment Production
5.5.2 China Neuroendocrine Tumors (NETs) Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroendocrine Tumors (NETs) Treatment Import and Export
5.6 Japan Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.6.1 Japan Neuroendocrine Tumors (NETs) Treatment Production
5.6.2 Japan Neuroendocrine Tumors (NETs) Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroendocrine Tumors (NETs) Treatment Import and Export
5.7 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.7.1 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Production
5.7.2 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Import and Export
5.8 India Neuroendocrine Tumors (NETs) Treatment Market Analysis
5.8.1 India Neuroendocrine Tumors (NETs) Treatment Production
5.8.2 India Neuroendocrine Tumors (NETs) Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroendocrine Tumors (NETs) Treatment Import and Export
6 Neuroendocrine Tumors (NETs) Treatment Segment Market Analysis (by Type)
6.1 Global Neuroendocrine Tumors (NETs) Treatment Production by Type
6.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue by Type
6.3 Neuroendocrine Tumors (NETs) Treatment Price by Type
7 Neuroendocrine Tumors (NETs) Treatment Segment Market Analysis (by Application)
7.1 Global Neuroendocrine Tumors (NETs) Treatment Consumption by Application
7.2 Global Neuroendocrine Tumors (NETs) Treatment Consumption Market Share by Application (2014-2019)
8 Neuroendocrine Tumors (NETs) Treatment Major Manufacturers Analysis
8.1 Advanced Accelerator Applications
8.1.1 Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.1.2 Advanced Accelerator Applications Product Introduction, Application and Specification
8.1.3 Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AVEO Oncology
8.2.1 AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.2.2 AVEO Oncology Product Introduction, Application and Specification
8.2.3 AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim International
8.3.1 Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.3.2 Boehringer Ingelheim International Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hutchison MediPharma Limited
8.4.1 Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.4.2 Hutchison MediPharma Limited Product Introduction, Application and Specification
8.4.3 Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 IpsenPharma
8.5.1 IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.5.2 IpsenPharma Product Introduction, Application and Specification
8.5.3 IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis AG
8.6.1 Novartis AG Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.6.2 Novartis AG Product Introduction, Application and Specification
8.6.3 Novartis AG Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer, Inc
8.7.1 Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.7.2 Pfizer, Inc Product Introduction, Application and Specification
8.7.3 Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Progenics Pharmaceuticals
8.8.1 Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
8.8.2 Progenics Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Neuroendocrine Tumors (NETs) Treatment Market
9.1 Global Neuroendocrine Tumors (NETs) Treatment Market Trend Analysis
9.1.1 Global Neuroendocrine Tumors (NETs) Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroendocrine Tumors (NETs) Treatment Regional Market Trend
9.2.1 North America Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.2.2 Europe Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.2.3 China Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.2.4 Japan Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.2.5 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.2.6 India Neuroendocrine Tumors (NETs) Treatment Forecast 2019-2025
9.3 Neuroendocrine Tumors (NETs) Treatment Market Trend (Product Type)
9.4 Neuroendocrine Tumors (NETs) Treatment Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Neuroendocrine Tumors (NETs) Treatment Distributors List
10.3 Neuroendocrine Tumors (NETs) Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Neuroendocrine Tumors (NETs) Treatment
Table Global Neuroendocrine Tumors (NETs) Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Neuroendocrine Tumors (NETs) Treatment Production Market Share by Types in 2018
Figure Somatostatin Analogs (SSAs) Product Picture
Figure Targeted Therapy Product Picture
Figure Other Product Picture
Table Global Neuroendocrine Tumors (NETs) Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Neuroendocrine Tumors (NETs) Treatment Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue (Million USD) (2014-2025)
Figure Global Neuroendocrine Tumors (NETs) Treatment Production (K Pcs) (2014-2025)
Figure North America Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Figure China Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Figure India Neuroendocrine Tumors (NETs) Treatment Market Size (Million USD) (2014-2025)
Table Neuroendocrine Tumors (NETs) Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuroendocrine Tumors (NETs) Treatment in 2018
Figure Manufacturing Process Analysis of Neuroendocrine Tumors (NETs) Treatment
Figure Industry Chain Structure of Neuroendocrine Tumors (NETs) Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neuroendocrine Tumors (NETs) Treatment Manufacturing Plants Distribution
Table Neuroendocrine Tumors (NETs) Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neuroendocrine Tumors (NETs) Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumors (NETs) Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumors (NETs) Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Neuroendocrine Tumors (NETs) Treatment Production Share by Manufacturers in 2018
Table Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumors (NETs) Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neuroendocrine Tumors (NETs) Treatment Revenue Share by Manufacturers in 2018
Table Neuroendocrine Tumors (NETs) Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neuroendocrine Tumors (NETs) Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Neuroendocrine Tumors (NETs) Treatment Production Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumors (NETs) Treatment Production Market Share by Regions in 2018
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Regions in 2018
Table Global Neuroendocrine Tumors (NETs) Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Neuroendocrine Tumors (NETs) Treatment Consumption Market Share by Regions 2014-2019
Figure North America Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure China Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure India Neuroendocrine Tumors (NETs) Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Neuroendocrine Tumors (NETs) Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Neuroendocrine Tumors (NETs) Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neuroendocrine Tumors (NETs) Treatment Market Share by Application (2014-2019)
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure IpsenPharma Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Novartis AG Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production Sites and Area Served
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Product Introduction, Application and Specification
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production Growth Rate (2014-2019)
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production Market Share (2014-2019)
Figure Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Revenue Market Share (2014-2019)
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Main Business and Markets Served
Figure Global Neuroendocrine Tumors (NETs) Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neuroendocrine Tumors (NETs) Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Neuroendocrine Tumors (NETs) Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Neuroendocrine Tumors (NETs) Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Neuroendocrine Tumors (NETs) Treatment by Application (2019-2025)
Table Neuroendocrine Tumors (NETs) Treatment Distributors List
Table Neuroendocrine Tumors (NETs) Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
消化管間質腫瘍（GIST）治療の世界市場：市場規模・現状・予測 A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.In 2018, the global Gastrointestinal Stromal Tumors (GISTs) Treatment market size was xx million US$ and it is expected to reach xx million US$ by…- 神経内分泌癌の世界市場：インサイト・予測 Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …
- 固形腫瘍用薬剤の世界市場：市場規模・現状・予測 Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.During 2017, the biolog…
- 世界のソマトスタチン受容体タイプ4市場：専門的調査 The global Somatostatin Receptor Type 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Somatostatin Receptor Type 4 volume and value at global level, regional level and company level. From a global…
- ソマトスタチンアナログの世界市場：インサイト・予測 Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. S…